A pilot study on symptomatic treatment of uncomplicated urinary tract infections in general practice.

Withdrawn

• Conditions: bladder infection; urinary tract infection; 10004018; 10046590

• Registration Number: NL-OMON34751
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

- Women, 18-45 years of age
- Symptoms and diagnosis of UTI, according to the *NHG-standaard* (symptoms: painful or burning micturition (dysuria), frequency, urgency, hematuria, suprapubic pain).
- Who have provided written informed consent to participate

Exclusion Criteria

Immunocompromised patients; pregnancy; diabetes mellitus; a known urological or nephrological disorder; fever, i.e. temperature above 38°C (axillary); pain in back and-or loin (kidney region); recurrent urinary tract infections (more than three occurrences per year during the past year or a UTI in the past three months); gynaecological complaints - such as abnormal vaginal discharge, labial irritation, intermittent vaginal bleeding; symptoms present for more than three days; taken antibiotics in the past four weeks.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary endpoint will be acceptability (percentage of women who agreed to<br /><br>participate in the study). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary endpoints will be number of *failures* and dropouts, compliance with<br /><br>the treatment, duration of symptoms, recurrence rates of urinary tract<br /><br>symptoms, complications of UTIs (pyelonephtitis, sepsis), hospital admission,<br /><br>quality of life as measured using SF12 health survey and absence from work.</p><br>